Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) is now available.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has announced the closure of two designated accounts for proceeds from a previous placement. The company had received approval from the China Securities Regulatory Commission to issue shares, and the proceeds from this placement were initially intended for specific projects. However, the company is now proposing to cease these projects and reallocate the remaining funds to working capital, indicating a strategic shift in financial management.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhongxin Pharmaceutical Group Corporation Limited, is a company incorporated in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.
For an in-depth examination of 2TZ stock, go to TipRanks’ Overview page.